CTIS2023-506512-40-00
Active, not recruiting
Phase 1
Effect of low-dose arginine-vasopressin supplementation on post-transplant Acute Kidney Injury after liver transplantation - AVENIR Trial - APHP220827
ConditionsAcute Kidney Injury, Liver transplantationMedDRA version: 21.0Level: LLTClassification code: 10024716Term: Liver transplantation Class: 10042613MedDRA version: 21.1Level: LLTClassification code: 10000821Term: Acute kidney failure Class: 10038359Therapeutic area: Diseases [C] - Digestive System Diseases [C06]Therapeutic area: Diseases [C] - Male Urogenital Diseases [C12]Therapeutic area: Diseases [C] - Female Urogenital Diseases and Pregnancy Complications [C13]
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Acute Kidney Injury, Liver transplantation
- Sponsor
- Assistance Publique Hopitaux De Paris
- Enrollment
- 304
- Status
- Active, not recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age \= 18 years, Any adult patient with a scheduled liver transplantation, All participants will need to be given clear information about the study and give signed informed consent, Person affiliated to the Social Security
Exclusion Criteria
- •Super\-emergency for liver transplantation or fulminant hepatitis, Pregnancy or breastfeeding, Patient listed for or receiving simultaneous liver\-kidney transplantation (SLKT), Patients with end\-stage renal disease (chronic eGFR \< 15 mL/min/1\.73 m2 or requiring extra\-renal purification before liver transplantation, Patient with epilepsy, Hypersensitivity to arginine\-vasopressin and to its excipients, Patient refusal, Patients for whom it is impossible to give informed consent (language barrier), Adults under guardianship or trusteeship, persons deprived of their liberty, Patient enrolled in another interventional clinical study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Effects of Arginine Supplementation associated with an Exercise Training Program in Chronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary Disease, Unspecified / Chronic Obstructive Pulmonary DiseaseRBR-8rkwnwniversidade Federal de Ciências da Saúde de Porto Alegre - UFCSPA
Completed
Not Applicable
The effect of Vasopressin on decreasing time of surgeryOvarian Endometrioma.Endometriosis of ovaryIRCT2013012512262N1Tehran University of Medical Science,14
Active, not recruiting
Phase 1
Pharmacological intervention study with L-arginin in prevention of diabete type II in patients affected by metabolic syndrome.EUCTR2005-004639-24-ITOSPEDALE S. RAFFAELE294
Completed
Not Applicable
The effect of L- arginine supplementation on metabolic syndrome.Metabolic Syndrome.-IRCT2015120425245N2for research of Yazd Shahid Sadoughi University of Medical Sciences60
Recruiting
Phase 1
Arginine effect on height growth of childreIRCT20230603058376N1Ardabil University of Medical Sciences76